Quantifying the Benefits of Targeting for Pandemic Response
Sergio Camelo, View ORCID ProfileDragos F. Ciocan, View ORCID ProfileDan A. Iancu, View ORCID ProfileXavier S. Warnes, View ORCID ProfileSpyros I. Zoumpoulis
doi: https://doi.org/10.1101/2021.03.23.21254155
Sergio Camelo
aInstitute for Computational and Mathematical Engineering, Stanford University
Dragos F. Ciocan
bTechnology and Operations Management, INSEAD
Dan A. Iancu
bTechnology and Operations Management, INSEAD
cOperations, Information & Technology, Graduate School of Business, Stanford University
Xavier S. Warnes
cOperations, Information & Technology, Graduate School of Business, Stanford University
Spyros I. Zoumpoulis
dDecision Sciences, INSEAD
Posted April 02, 2021.
Quantifying the Benefits of Targeting for Pandemic Response
Sergio Camelo, Dragos F. Ciocan, Dan A. Iancu, Xavier S. Warnes, Spyros I. Zoumpoulis
medRxiv 2021.03.23.21254155; doi: https://doi.org/10.1101/2021.03.23.21254155
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2936)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12740)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4579)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4346)
- Nursing (236)
- Nutrition (638)
- Oncology (2268)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)